DIO1 and fatty liver disease: Xia et al. [60] reported that mice with an obese phenotype experienced ameliorated hepatic steatosis if the intervention was exercise, low-fat, quercetin or calorie restriction, possibly by affecting miRNAs, e.g. miR-383 and miR-146b to elevate DIO1 expression.